fluspirilene has been researched along with Carcinoma, Hepatocellular in 1 studies
Fluspirilene: A long-acting injectable antipsychotic agent used for chronic schizophrenia.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, XN | 1 |
| Li, H | 1 |
| Yao, H | 1 |
| Liu, X | 1 |
| Li, L | 1 |
| Leung, KS | 1 |
| Kung, HF | 1 |
| Lu, D | 1 |
| Wong, MH | 1 |
| Lin, MC | 1 |
1 other study available for fluspirilene and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug.
Topics: Animals; Antipsychotic Agents; Carcinoma, Hepatocellular; Computer Simulation; Cyclin-Dependent Kina | 2015 |